Titre : Hepatitis C Treatment With Direct-Acting Antivirals Confers Survival Benefit
link : Hepatitis C Treatment With Direct-Acting Antivirals Confers Survival Benefit
Hepatitis C Treatment With Direct-Acting Antivirals Confers Survival Benefit
In Case You Missed ItToday over at Infectious Disease Advisor, media coverage on the study; Effect of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ledipasvir/Sofosbuvir Regimens on Survival Compared With Untreated Hepatitis C Virus–Infected Persons: Results From ERCHIVES, is highlighted, the full-text article shared by @HenryEChang via Twitter, can be reviewed here.
Links
Hepatitis C Treatment With Direct-Acting Antivirals Confers Survival Benefit
October 11, 2017
Among patients with hepatitis C, direct-acting antiviral regimens paritaprevir/ritonavir, ombitasvir, and dasabuvir (PrOD) and ledipasvir/sofosbuvir (LDV/SOF) were shown to be associated with a significant improvement in survival, according to the results of a study published in Clinical Infectious Diseases ...
Full-Text Article
Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ledipasvir/Sofosbuvir Regimens on Survival Compared With Untreated Hepatitis C Virus–Infected Persons: Results From ERCHIVES
Thus articles Hepatitis C Treatment With Direct-Acting Antivirals Confers Survival Benefit
that is all articles Hepatitis C Treatment With Direct-Acting Antivirals Confers Survival Benefit This time, hopefully can provide benefits to you all. Okay, see you in another article post.
You are now reading the article Hepatitis C Treatment With Direct-Acting Antivirals Confers Survival Benefit the link address https://newsaninpiration.blogspot.com/2017/10/hepatitis-c-treatment-with-direct.html
0 Response to "Hepatitis C Treatment With Direct-Acting Antivirals Confers Survival Benefit"
Post a Comment